| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institute of Veterinary Physiology, University of Zurich, 8057 Zurich, Switzerland; and 2 Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio 45267
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
We investigated the role of histamine H1 receptors in mediating the anorectic effect of intraperitoneally injected amylin (5 and 20 µg/kg), the amylin agonist salmon calcitonin (sCT; 10 µg/kg), leptin (1.3 mg/kg), and cholecystokinin (CCK; 20 µg/kg). The experiments were performed with mice lacking functional H1 receptors (H1Rko) and wild-type (WT) controls. The mice were also injected with the H3 antagonist thioperamide (20 mg/kg), which reduces feeding by enhancing the release of endogenous histamine through presynaptic H3 receptors. The feeding-suppressive effect of thioperamide was abolished in H1Rko mice. The anorectic effects of amylin and sCT were significantly reduced in 12-h food-deprived H1Rko mice compared with WT mice [1-h food intake: WT-NaCl 0.51 ± 0.05 g vs. WT-amylin (5 µg/kg) 0.30 ± 0.06 g (P < 0.01); H1Rko-NaCl 0.45 ± 0.05 g vs. H1Rko-amylin 0.40 ± 0.04 g; WT-NaCl 0.40 ± 0.09 g vs. WT-sCT (10 µg/kg) 0.14 ± 0.10 g (P < 0.05); H1Rko-NaCl 0.44 ± 0.08 g vs. H1Rko-sCT 0.50 ± 0.06 g]. The anorectic effect of leptin was absent in ad libitum-fed H1Rko mice, whereas CCK equally reduced feeding in WT and H1Rko animals. This suggests that the histaminergic system is involved in mediating the anorectic effects of peripheral amylin and sCT via histamine H1 receptors. The same applies to leptin but not to CCK. H1Rko mice showed significantly increased body weight gain compared with WT mice, supporting the role of endogenous histamine in the regulation of feeding and body weight.
food intake; histamine H1 receptor knockout mice; thioperamide; salmon calcitonin; leptin; cholecystokinin
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
AMYLIN, A
37-AMINO ACID POLYPEPTIDE that is secreted
from pancreatic 
-cells in response to food intake, has been shown to suppress feeding in rats and mice mainly by decreasing meal size (9, 12, 26). Its satiating action is specific, since
amylin does not induce a conditioned taste aversion (3,
12). Peripheral amylin has a central site of action
(8-10, 20), and the area postrema (AP) of the
hindbrain plays the predominant role in mediating the inhibitory effect
of amylin on feeding (13). The anorectic effect of amylin
is markedly attenuated in AP-lesioned rats (13) and is
mediated by a direct activation of amylin-sensitive neurons in the AP
(23, 25).
Although the primary site of action for the satiating effect of
peripheral amylin is clear, knowledge about the neurotransmitters and
signaling pathways that are involved in mediating amylin's satiating
effect in the central nervous system (CNS) is limited. Previous studies
have shown that amylin's satiating effect is partially mediated by the
central dopaminergic, but not serotoninergic (11), system
because blockade of dopamine D2 receptors attenuated amylin's anorectic effect (14). Furthermore, because
injection of the H3 agonists imetit and
R-
-methylhistamine, which block the release of endogenous
histamine via presynaptic histamine H3 receptors, reduced
amylin's inhibitory effect on feeding, the histaminergic system also
seems to play an important role in mediating amylin's satiating effect
(11).
Because within the CNS, histamine's inhibitory effect on feeding mainly seems to involve histamine H1 receptors (17, 27, 28), the aim of the present study was to investigate whether histamine mediates amylin's satiating effect via this receptor subtype. Histamine H1 receptors have also been found in the AP/nucleus of the solitary tract (AP/NTS) region, which is involved in mediating the anorectic effect of amylin (13), and in hypothalamic areas (27, 28). To investigate the importance of histamine H1 receptors in the signaling transmission of the anorectic effect of amylin, we treated histamine H1 receptor knockout (H1Rko) mice with amylin and compared the anorectic effect in these mice to that in respective wild-type (WT) controls. We also tested the effect of salmon calcitonin (sCT) on food intake in these animals because sCT has been shown to reduce food intake via amylin binding sites (15). To confirm the lack of H1 receptors in the H1Rko mice, they were first injected with thioperamide, an H3 receptor antagonist that decreases food intake by enhancing the release of endogenous histamine (16, 27). Leptin, the ob gene product that is secreted from white adipose tissue and is involved in the regulation of food intake and body weight by acting on hypothalamicarcuate nucleus neurons (2, 31), was used as a positive control because its anorectic effect has been reported to be absent in H1Rko mice (18). Cholecystokinin (CCK) was also included in the study because the anorectic effect of CCK does not seem to depend on the histaminergic system (33).
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Animals and Housing Conditions
The experiments were performed with knockout mice lacking functional histamine H1 receptors (H1Rko; strain C57BL) and respective WT controls (strain C57BL). The H1Rko mice were generated by homologous recombination (7) and appear phenotypically normal but show increased ambulation during the light period, decreased locomotor activity in the dark period, and reduced exploratory behavior in a new environment (7). [3H]pyrilamine and doxepin binding studies were used to verify the lack of H1 receptors (7).Adult male H1Rko and WT mice, respectively, were used. The average age was ~3.5 mo when they were used for the first time in the feeding experiments. The animals were housed in standard wire cages (24 × 25 × 18 cm) at a room temperature of 21 ± 1°C and with an artificial inversed 12:12-h light-dark cycle (lights on at 2100). The mice were adapted to the housing conditions for at least 3-4 wk before the experiments. Mice had ad libitum access to water and food (powdered medium-fat diet containing 13% protein, 46% corn starch, and 18% fat, with an energy density of 16.5 kJ/g; Kliba Mühlen, Kaiseraugst, Switzerland) except during food deprivation just before the experiments (see below). Body weight was registered at weekly intervals.
Drugs and Experimental Design
Rat amylin, sCT, and CCK octapeptide (CCK-8) were obtained from Peninsula Laboratories (Belmont, CA). Mouse recombinant leptin and the H3 antagonist thioperamide were obtained from RBI Products/Sigma (St. Louis, MO). All peptides were freshly dissolved in 0.9% NaCl just before the experiments. The H3 antagonist thioperamide was dissolved in sterile 0.5% sodium carboxymethylcellulose (CMC) solution. Amylin was injected at doses of 5 and 20 µg/kg and the amylin receptor agonist sCT at doses of 1 and 10 µg/kg. Leptin (1.3 mg/kg) was used as a positive control (18). CCK (20 µg/kg) was included in the study because its anorectic effect is reported not to depend on the histaminergic system (33). To confirm the lack of functional histamine H1 receptors, mice were also injected with thioperamide (20 mg/kg), a selective H3 receptor antagonist (1) that, by enhancing the release of endogenous histamine, has been shown to reduce food intake in rats (16, 27).For each experiment, H1Rko and WT mice were randomly divided into two groups, each with similar body weight. The order of treatment was randomized. When a crossover design was used (see below), at least 5 days were allowed for recovery between tests.
All solutions were injected intraperitoneally with an injection volume of 10 ml/kg. Injection of the same volume of the appropriate solvent served as control. Food was presented just after the injections. All experiments were performed at dark onset (0900). Food intake was assessed by measuring the weight of the food containers (±0.1 g) after correcting for food spillage and removing feces and urine. To prevent disturbance of the mice by light during the dark period, the measurement was performed under red light.
Experiment 1. H1Rko (n = 15; 30.3 ± 0.6 g) and WT mice (n = 16; 27.8 ± 0.5 g) were food deprived for 12 h during the light period (2100-0900). Thioperamide (20 mg/kg) or vehicle (0.5% sodium-CMC solution) were injected at dark onset (0900). The experiment was performed using a crossover design so that each animal served as its own control.
Experiment 2. For amylin at 5 µg/kg, WT mice had an average body weight of 28.2 ± 0.5 g (n = 16), and H1Rko mice had an average body weight of 29.8 ± 0.8 g (n = 15). For amylin at 20 µg/kg, WT mice had an average body weight of 26.8 ± 0.6 g (n = 16), and H1Rko mice had an average body weight of 29.2 ± 0.7 g (n = 16). The animals were food deprived for 12 h during the light phase (2100-0900). Amylin (5 or 20 µg/kg) or vehicle was injected intraperitoneally immediately before dark onset (0900). Each experiment was performed using a crossover design.
Experiment 3. For sCT at 10 µg/kg, WT mice had an average body weight of 26.6 ± 0.4 g (n = 16), and H1Rko mice had an average body weight of 28.1 ± 0.6 g (n = 15). For sCT at 1 µg/kg, WT mice had an average body weight of 30.8 ± 0.8 g (n = 15), and H1Rko mice had an average body weight of 34.1 ± 0.6 g (n = 16). WT and H1Rko mice were injected intraperitoneally with sCT (1 or 10 µg/kg) or vehicle immediately before dark onset (0900) after 12-h food deprivation.
Experiment 4. The experimental procedure was similar to that in the study by Morimoto et al. (18). Ad libitum-fed WT (n = 16; 27.7 ± 0.4 g) and H1Rko mice (n = 15; 29.6 ± 0.6 g) received an intraperitoneal injection of leptin at a dose of 1.3 mg/kg or vehicle at dark onset (0900). The experiment was performed using a crossover design.
Experiment 5. Twelve-hour food-deprived H1Rko (n = 16; 31.1 ± 0.6 g) and WT mice (n = 16; 28.7 ± 0.8 g) were injected with CCK-8 (20 µg/kg) or vehicle at dark onset (0900).
Statistics
Results are presented as means ± SE. The treatment groups were compared using one-way or, when a crossover design was used, repeated-measures ANOVA with the Student-Newman-Keuls post hoc test or paired Student's t-test. The influence of the absence of functional histamine H1 receptors in the H1Rko mice on the effects of the tested substances on food intake was investigated by two-factor ANOVA. Body weight, which was assessed at weekly intervals, was compared using the unpaired Student's t-test.In all cases, P < 0.05 was considered significant.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Experiment 1
Thioperamide (20 mg/kg) significantly reduced 1-h cumulative food intake in WT mice (paired Student's t-test) by ~40% [food intake 1 h after injection: WT-vehicle (n = 16) 0.49 ± 0.05 g vs. WT-thioperamide (n = 15) 0.29 ± 0.07 g; P < 0.05]. In H1Rko mice, thioperamide did not reduce feeding [food intake 1 h after injection: H1Rko-vehicle (n = 15) 0.36 ± 0.04 g vs. H1Rko-thioperamide (n = 15) 0.43 ± 0.06 g]. Because thioperamide's anorectic effect was completely abolished in the H1Rko mice (2-factor ANOVA: 1 h, P < 0.05), this experiment confirms the ablation of functional H1 receptors in these animals.Experiment 2
In experiment 2, amylin was injected at 5 or 20 µg/kg. In WT mice, amylin (5 µg/kg) significantly (paired Student's t-test) reduced cumulative food intake throughout the 4-h observation period by ~20-40%. Amylin's anorectic effect was completely abolished in H1Rko mice (Fig. 1A) (2-factor ANOVA: 4 h, P < 0.05).
|
At a dose of 20 µg/kg, amylin significantly (repeated- measures ANOVA) reduced food intake throughout the 4-h observation period in WT mice. In H1Rko mice, amylin only slightly reduced feeding, without reaching the level of significance (Fig. 1B).
Experiment 3
In experiment 3, sCT was injected at 1 or 10 µg/kg. sCT (10 µg/kg) significantly (1-way ANOVA) reduced feeding in WT mice by ~40-65% but had no effect on cumulative food intake in H1Rko mice (Fig. 2A) (2-factor ANOVA, interaction between the lack of H1 receptors and the effect of treatment: 1 h, P < 0.05; 2 h, P < 0.05; 4 h, P < 0.05; and 8 h, P < 0.05).
|
The experiment was also performed with chow-fed mice at a dose of 1 µg/kg sCT. Under these conditions, sCT significantly (1-way ANOVA) reduced cumulative food intake in WT mice by ~20-55% but not in H1Rko mice (Fig. 2B) (2-factor ANOVA, interaction between the lack of H1 receptors and the effect of treatment: 1 h, P < 0.05; 2 h, P < 0.01; 4 h, P < 0.01; and 8 h, P < 0.05).
Experiment 4
Leptin (1.3 mg/kg) significantly (paired Student's t-test) reduced cumulative food intake in WT mice by ~10-30%, whereas in H1Rko mice, its anorectic effect was completely abolished (Fig. 3) (2-factor ANOVA: 6 h, P < 0.05; 12 h, P = 0.06).
|
Experiment 5
In experiment 5, CCK-8 was injected at 20 µg/kg. Cumulative food intake was significantly (1-way ANOVA) reduced by CCK-8 throughout the 2-h observation period in both WT and H1Rko mice (Fig. 4). The two-factor ANOVA showed that the absence of the histamine H1 receptor in H1Rko mice did not influence the anorectic effect of CCK-8. In another experiment, CCK-8 was used at a dose of 5 µg/kg. In this case, CCK-8 tended to reduce feeding in WT and H1Rko mice, but the effects were not significant [e.g., food intake 1 h after injection (body weight of: WT 27.7 ± 0.6 g, n = 16; H1Rko 28.5 ± 0.7 g, n = 16): WT-NaCl 0.48 ± 0.04 g vs. WT-CCK 0.38 ± 0.08 g; H1Rko-NaCl 0.52 ± 0.05 g vs. H1Rko-CCK 0.38 ± 0.05 g].
|
All experiments (except with CCK-8) were repeated using another group of H1Rko and WT mice. In all cases, the outcome was as described before, i.e., the anorectic effects of thioperamide, amylin, sCT, and leptin, which were significant in WT mice, were abolished in H1Rko animals (results not shown).
We observed a significantly increased body weight gain in
H1Rko mice compared with WT animals (Fig.
5). In H1Rko mice, basal food
intake tended to be higher by ~5% than in WT control mice, but this
effect was not significant (data not shown).
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
In this study, we have shown that functional histamine H1 receptors are essential for the anorectic effects of intraperitoneally administered amylin and sCT. In contrast to WT animals, in which amylin markedly reduced feeding, the anorectic action of amylin was absent in H1Rko mice when a dose of 5 µg/kg was used. At the higher amylin dose (20 µg/kg), only a slight nonsignificant reduction in feeding was observed in H1Rko mice. Interestingly, the inhibitory effect of sCT on feeding was also completely abolished in H1Rko mice at both doses of sCT (1 and 10 µg/kg). sCT is structurally and functionally related to amylin (5) and seems to reduce feeding by interaction with amylin receptors (15). In previous studies, a stronger and prolonged effect of sCT compared with amylin was observed (15). This can be explained by the irreversible binding of sCT to amylin receptors (21), causing a persistent neuronal activation (24).
To verify the ablation of histamine H1 receptors in the H1Rko mice, we injected these mice with the H3 antagonist thioperamide, which reduces food intake in rats (16, 27) by enhancing the synthesis and release of endogenous histamine (1). It has been shown that histamine reduces feeding mainly via histamine H1 receptors (17, 28). The lack of an anorectic effect of thioperamide in H1Rko mice compared with WT animals confirms the absence of functional histamine H1 receptors in H1Rko mice.
The findings of the present experiments complement our previous study
(11) demonstrating a mediation of amylin's anorectic effect by the histaminergic system. The pretreatment with the H3 receptor agonists imetit and
R--methylhistamine, which are able to penetrate the
blood-brain barrier and block the release of endogenous histamine via
presynaptic histamine H3 receptors, reduced amylin's
inhibitory effect on feeding in rats (11). We now show
that histamine mediates amylin's satiating effect through
H1 receptors.
Hypothalamic histamine is well known to be involved in the regulation of food intake and body weight (16, 17, 27-29). Increased concentrations of central histamine are able to reduce feeding via histamine H1 receptors (17, 28), whereas a blockade of central histamine H1 receptors (28) increases food intake. Additional studies showed that the H1 receptors in the ventromedial (VMH) and paraventricular hypothalamic nuclei, which are the areas richest in hypothalamic histamine and H1 receptors (29, 30), play the major role in this regard (29). We therefore conclude that the amylin-induced activation of AP neurons that underlies the anorectic effect of peripheral amylin (13, 23, 25) directly or indirectly leads to an increase in hypothalamic histamine release to bring about amylin's effect by acting on hypothalamic histamine H1 receptors. This main conclusion of our present study is corroborated by preliminary findings that an infusion of the H1 receptor antagonist chlorpheniramine into the VMH blocked the anorectic effect of peripheral amylin in rats (unpublished data).
In previous studies, we showed that the dopaminergic system is also involved in mediating amylin's satiating effect because blockade of D2 receptors attenuates amylin's action in rats (14). In another study, a high density of dopamine D2 receptors has been detected in the AP/NTS region (22). In analogy to a blockade of the anorectic effect of amylin by H1 antagonists into the VMH, we recently demonstrated that an infusion of the dopamine D2 antagonist raclopride directly into the AP/NTS region also attenuates the amylin-induced reduction of feeding (unpublished observations). We therefore propose that at least a dopaminergic system in the brain stem and a histaminergic hypothalamic mechanism (e.g., in the VMH) are involved in the ascending signaling pathway mediating the anorectic effect of amylin.
Because activation of presynaptic H3 receptors, which attenuates amylin's satiating effect (11), not only reduces the release of histamine but, via receptors on nonhistaminergic neurons, also the release of dopamine (4), it could theoretically be possible that the attenuation of amylin's anorectic effect by histamine H3 agonists (11) was due to an inhibition of dopamine rather than histamine release. However, we showed in the present study that amylin's anorectic effect was markedly reduced in H1Rko mice. It is therefore unlikely that the attenuating effect of H3 agonists on amylin's satiating action (11) is due to an inhibition of dopamine release. Instead of a direct interaction between the dopaminergic and the histaminergic systems, we suggest the model presented above with dopamine in the AP/NTS region and histamine in the VMH as sequential mediators of amylin's anorectic effect.
In our study, we observed an increased body weight gain in H1Rko mice compared with the WT control animals. Higher body weight appeared to be associated with an increased fat pad mass (unpublished observations). This was paralleled by an increase in basal food intake in the H1Rko mice, although the latter effect was not significant. Over time, however, the higher food intake probably contributes to the observed differences in body weight (and fat mass). These findings underline the overall importance of the histaminergic system and H1 receptors in the regulation of food intake and body weight (29).
Our results support previous findings that the histaminergic system
plays an important role in the feeding-suppressive effect of
intraperitoneally administered leptin. Morimoto et al. (18, 19) and Yoshimatsu et al. (35) have shown that the
central histaminergic system is involved in leptin's anorectic effect because the specific histidine decarboxylase inhibitor
-fluoromethylhistidine abolished the anorectic effect of leptin in
mice and because leptin's inhibitory effect on feeding was absent in
H1Rko mice (18, 35). The latter effect was
confirmed in the present study. It is possible that leptin is able to
reduce feeding in H1Rko mice when administered at higher
doses, indicating that other neurotransmitters are also involved in
leptin action (2, 34). A similar conclusion can be drawn
for amylin, which, at the high dose used (20 µg/kg), appeared to
produce some weak, albeit nonsignificant, reduction in feeding in the
H1Rko mice.
The findings of this and other studies (18, 35) that the anorectic effects of both amylin and leptin are mediated via histamine H1 receptors raise the question as to whether the central nervous signaling pathways for amylin, which acts through activation of AP neurons (13, 23, 25), and leptin, which acts primarily via arcuate hypothalamic nucleus neurons (31, 34), converge via the histaminergic system in the VMH.
We also injected the mice with CCK, which acts as an important satiating peptide (6). We have shown that CCK reduces food intake with equal potency in both H1Rko and WT mice compared with saline controls. Consequently, histamine H1 receptors are not necessary in the transmission of the anorectic action of CCK. These data not only confirm previous studies demonstrating that the anorectic effect of CCK does not depend on the histaminergic but rather the serotoninergic system (33), but also underline the specificity of the observed effects in our present investigations.
In conclusion, we have shown that the histaminergic system is involved in mediating the anorectic effects of amylin, sCT, and leptin but not CCK through histamine H1 receptors in mice. Furthermore, H1Rko mice showed significantly increased body weight gain compared with the WT animals, supporting the role of endogenous histamine in the regulation of food intake and body weight.
Perspectives
The results of this and other studies have shown that histamine via H1 receptors and dopamine via D2 receptors (14) are involved in mediating the anorectic effect of amylin. As discussed, it is not clear where in the CNS these neurotransmitter systems that are involved in amylin's satiating effect are located. Some evidence indicates, however, that the amylin-induced activation of AP neurons, which seems to underlie the anorectic action of peripheral amylin (13, 23, 25), leads to a release of dopamine that acts locally on D2 receptors of other neurons that then directly or indirectly influence hypothalamic histamine release to bring about amylin's effect by acting on hypothalamic histamine H1 receptors, e.g., in the VMH.The findings that the anorectic effects of both amylin and leptin are partly mediated via histamine H1 receptors (18, 35) raise the question as to whether the central nervous signaling pathways for amylin, which acts on AP neurons (13, 23, 25), and leptin, which acts primarily via arcuate hypothalamic nucleus neurons (31, 34), converge via the histaminergic system in the VMH. It also remains to be investigated whether this convergence could be the neuroanatomical basis for a modulation of the anorectic action of the satiating peptide amylin, a possible signal for direct control of meal size (32), by leptin, a signal for indirect control of meal size (32). Future studies will have to address these open questions by a combination of feeding studies and other experimental techniques to clarify the ascending signaling pathway for the anorectic action of amylin and its interaction with other anorectic agents. It also remains to be investigated whether other neurotransmitters and/or neuropeptides in the CNS feeding centers are affected by amylin.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Professor T. Watanabe (Kyushu Univ., Fukuoka, Japan) for donation of the H1Rko mice and the Institute of Laboratory Animals (Univ. of Zurich, Zurich, Switzerland) for breeding them.
| |
FOOTNOTES |
|---|
The financial support of the Swiss National Research Foundation is gratefully acknowledged (grant no. 31-58799.99).
Address for reprint requests and other correspondence: T. A. Lutz, Institute of Veterinary Physiology, Univ. of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland (E-mail: tomlutz{at}vetphys.unizh.ch).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 8 February 2001; accepted in final form 18 July 2001.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Arrang, JM,
Garbarg M,
Lancelot JC,
Lecomte JM,
Pollard H,
Robba M,
Schunack W,
and
Schwartz JC.
Highly potent and selective ligands for histamine H3-receptors.
Nature
327:
117-123,
1987[Medline].
2.
Baskin, DG,
Hahn TM,
and
Schwartz MW.
Leptin sensitive neurons in the hypothalamus.
Horm Metab Res
31:
345-350,
1999[ISI][Medline].
3.
Chance, WT,
Balasubramaniam A,
Chen X,
and
Fischer JE.
Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin.
Peptides
13:
961-964,
1992[ISI][Medline].
4.
Chiavegatto, S,
Nasello AG,
and
Bernardi MM.
Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system.
Life Sci
62:
1875-1888,
1998[ISI][Medline].
5.
Cooper, GJS
Amylin compared with CGRP: structure, biology and relevance to metabolic disease.
Endocr Rev
15:
163-201,
1994[ISI][Medline].
6.
Gibbs, J,
Young RC,
and
Smith GP.
Cholecystokinin decreases food intake in rats.
J Comp Physiol Psychol
84:
488-495,
1973[ISI][Medline].
7.
Inoue, I,
Yanai K,
Kitamura D,
Taniuchi I,
Kobayashi T,
Niimura K,
Watanabe T,
and
Watanabe T.
Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors.
Proc Natl Acad Sci USA
93:
13316-13320,
1996
8.
Lutz, TA,
Althaus J,
Rossi R,
and
Scharrer E.
The anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibres.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R1777-R1782,
1998
9.
Lutz, TA,
Del Prete E,
and
Scharrer E.
Reduction of food intake in rats by intraperitoneal injection of low doses of amylin.
Physiol Behav
55:
891-895,
1994[Medline].
10.
Lutz, TA,
Del Prete E,
and
Scharrer E.
Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.
Peptides
16:
457-462,
1995[ISI][Medline].
11.
Lutz, TA,
Del Prete E,
Walzer B,
and
Scharrer E.
The histaminergic but not the serotoninergic system mediates amylin's anorectic effect.
Peptides
17:
1317-1322,
1996[ISI][Medline].
12.
Lutz, TA,
Geary N,
Szabady MM,
Del Prete E,
and
Scharrer E.
Amylin decreases meal size in rats.
Physiol Behav
58:
1197-1202,
1995[Medline].
13.
Lutz, TA,
Senn M,
Althaus J,
Del Prete E,
Ehrensperger F,
and
Scharrer E.
Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats.
Peptides
19:
309-317,
1998[ISI][Medline].
14.
Lutz, TA,
Tschudy S,
Mollet A,
Geary N,
and
Scharrer E.
Dopamine D2-receptors mediate amylin's acute satiety effect.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1697-R1703,
2001
15.
Lutz, TA,
Tschudy S,
and
Scharrer E.
Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
Peptides
21:
233-238,
2000[ISI][Medline].
16.
Machidori, H,
Sakata T,
Yoshimatsu H,
Ookuma K,
Fujimoto K,
Kurokawa M,
Yamatodani A,
and
Wada H.
Zucker obese rats: defect in brain histamine control of feeding.
Brain Res
590:
180-186,
1992[ISI][Medline].
17.
Mercer, LP,
Kelley DS,
Humphries LL,
and
Dunn JD.
Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats.
J Nutr
124:
1029-1036,
1994.
18.
Morimoto, T,
Yamamoto Y,
Mobarakeh JI,
Yanai K,
Watanabe T,
Watanabe T,
and
Yamatodani A.
Involvement of the histaminergic system in leptin-induced suppression of food intake.
Physiol Behav
67:
679-683,
1999[Medline].
19.
Morimoto, T,
Yamamoto Y,
and
Yamatodani A.
Leptin facilitates histamine release from the hypothalamus in rats.
Brain Res
868:
367-369,
2000[ISI][Medline].
20.
Morley, JE,
Flood JF,
Horowitz M,
Morley PMK,
and
Walter MJ.
Modulation of food intake by peripherally administered amylin.
Am J Physiol Regulatory Integrative Comp Physiol
267:
R178-R184,
1994
21.
Muff, R,
Born W,
and
Fischer JA.
Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions.
Eur J Endocrinol
133:
17-20,
1995[Abstract].
22.
Qian, M,
Johnson AE,
Kallstrom L,
Carrer H,
and
Södersten P.
Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: possible relationship to ingestive behavior.
Neuroscience
77:
1077-1089,
1997[ISI][Medline].
23.
Riediger, T,
Lutz TA,
Schmid HA,
and
Scharrer E.
The area postrema as a major target for peptides controlling food intake.
Soc Neurosci Abstr
26 (369):
10,
2000.
24.
Riediger, T,
Schmid HA,
Young AA,
and
Simon E.
Pharmacological characterization of amylin-related peptides activating subfornical organ neurons.
Brain Res
837:
161-168,
1999[ISI][Medline].
25.
Rowland, NE,
Crews EC,
and
Gentry RM.
Comparison of Fos induced in rat brain by GLP-1 and amylin.
Regul Pept
71:
171-174,
1997[ISI][Medline].
26.
Rushing, PA,
Seeley RJ,
and
Woods SC.
Intravenous amylin transiently reduces food intake in non deprived rats.
Soc Neurosci Abstr
24:
1019,
1998.
27.
Sakata, T,
Fukagawa K,
Ookuma K,
Fujimoto K,
Yoshimatsu H,
Yamatodani A,
and
Wada H.
Hypothalamic neuronal histamine modulates ad libitum feeding by rats.
Brain Res
537:
303-306,
1990[ISI][Medline].
28.
Sakata, T,
Ookuma K,
Fukagawa K,
Fujimoto K,
Yoshimatsu H,
Shiraishi T,
and
Wada H.
Blockade of the histamine H1 receptor in the rat ventromedial hypothalamus and feeding elicitation.
Brain Res
441:
404-407,
1988.
29.
Sakata, T,
Yoshimatsu H,
and
Kurokawa M.
Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism.
Nutrition
13:
403-411,
1997[ISI][Medline].
30.
Schwartz, JC,
Arrang JM,
Garbarg M,
Pollard H,
and
Ruat M.
Histaminergic transmission in the mammalian brain.
Physiol Rev
71:
1-51,
1991
31.
Schwartz, MW,
Seeley RJ,
Campfield LA,
Burn P,
and
Baskin DG.
Identification of targets of leptin action in rat hypothalamus.
J Clin Invest
98:
1101-1106,
1996[ISI][Medline].
32.
Smith, GP.
The direct and indirect controls of meal size.
Neurosci Biobehav Rev
20:
41-46,
1996[ISI][Medline].
33.
Stallone, D,
Nicolaidis S,
and
Gibbs J.
Cholecystokinin-induced anorexia depends on serotoninergic function.
Am J Physiol Regulatory Integrative Comp Physiol
256:
R1138-R1141,
1989
34.
Woods, SC,
Seeley RJ,
Porte D, Jr,
and
Schwartz MW.
Signals that regulate food intake and energy homeostasis.
Science
280:
1378-1383,
1998
35.
Yoshimatsu, H,
Itateyama E,
Kondou S,
Tajima D,
Himeno K,
Hidaka S,
Kurokawa M,
and
Sakata T.
Hypothalamic neuronal histamine as a target of leptin in feeding behavior.
Diabetes
48:
2286-2291,
1999[Abstract].
This article has been cited by other articles:
|
|
 |
|
  N. T. Bello, M. H. Kemm, and T. H. Moran Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R76 - R81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Lutz Hunger and satiety: one brain for two? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R900 - R902. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yoshimoto, Y. Miyamoto, K. Shimamura, A. Ishihara, K. Takahashi, H. Kotani, A. S. Chen, H. Y. Chen, D. J. MacNeil, A. Kanatani, et al. Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus PNAS, September 12, 2006; 103(37): 13866 - 13871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kim, T. P. Stewart, W. Zhang, H. Y. Kim, P. M. Nishina, and J. K. Naggert Type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary obesity Physiol Genomics, July 14, 2005; 22(2): 171 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Masaki, S. Chiba, T. Yasuda, H. Noguchi, T. Kakuma, T. Watanabe, T. Sakata, and H. Yoshimatsu Involvement of Hypothalamic Histamine H1 Receptor in the Regulation of Feeding Rhythm and Obesity Diabetes, September 1, 2004; 53(9): 2250 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cupples Peptides that regulate food intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1370 - R1374. [Full Text] [PDF]
|
|
|
|
|
|
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cupples Regulation of body weight Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1264 - R1266. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
